We are live on ! Find out more
CLOV icon

Clover Health Investments

178 hedge funds and large institutions have $293M invested in Clover Health Investments in 2024 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 62 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $27M | Put options by funds: $12.2M

95% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 20

88% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 33

27% more capital invested

Capital invested by funds: $231M → $293M (+$61.4M)

12% more funds holding

Funds holding: 159178 (+19)

2.43% more ownership

Funds ownership: 20.12%22.55% (+2.4%)

Holders
178
Holders Change
+19
Holders Change %
+11.95%
% of All Funds
2.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
62
Reduced
33
Closed
20
Calls
$27M
Puts
$12.2M
Net Calls
+$14.9M
Net Calls Change
+$3.41M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$61.7M +$1.38M +386,499 +2%
Renaissance Technologies
2
Renaissance Technologies
New York
$34.9M -$5.05M -1,413,300 -11%
BlackRock
3
BlackRock
New York
$31.6M +$1.49M +417,514 +4%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$15.4M +$192K +53,760 +1%
Qube Research & Technologies (QRT)
5
Qube Research & Technologies (QRT)
United Kingdom
$14.8M +$6.97M +1,949,126 +71%
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$14.1M -$1.22M -341,838 -7%
Marshall Wace
7
Marshall Wace
United Kingdom
$11.9M +$8.44M +2,360,902 +168%
State Street
8
State Street
Massachusetts
$8.81M +$2.17M +608,381 +28%
Charles Schwab
9
Charles Schwab
California
$8.67M -$891K -249,448 -8%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$8.63M +$3.08M +860,480 +46%
Goldman Sachs
11
Goldman Sachs
New York
$7.21M +$6.4M +1,789,947 +358%
Morgan Stanley
12
Morgan Stanley
New York
$4.98M +$244K +68,246 +5%
Invesco
13
Invesco
Georgia
$4.37M -$29.9K -8,374 -0.6%
Millennium Management
14
Millennium Management
New York
$3.92M +$4.37M +1,221,612 +5,071%
Northern Trust
15
Northern Trust
Illinois
$3.42M +$535K +149,714 +16%
Connor, Clark & Lunn Investment Management (CC&L)
16
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.29M -$302K -84,628 -8%
Citadel Advisors
17
Citadel Advisors
Florida
$2.87M +$2.74M +767,454 +534%
Teacher Retirement System of Texas
18
Teacher Retirement System of Texas
Texas
$2.77M +$3.14M +878,936 New
UBS AM
19
UBS AM
Illinois
$2.62M +$1.41M +394,881 +91%
Swiss National Bank
20
Swiss National Bank
Switzerland
$2.53M +$170K +47,700 +6%
American Century Companies
21
American Century Companies
Missouri
$2.41M +$1.76M +492,527 +181%
SSA
22
Schonfeld Strategic Advisors
New York
$1.86M +$2.11M +590,571 New
Jane Street
23
Jane Street
New York
$1.68M +$842K +235,595 +79%
Two Sigma Investments
24
Two Sigma Investments
New York
$1.59M -$4.06M -1,134,656 -69%
Barclays
25
Barclays
United Kingdom
$1.45M +$1.27M +355,926 +337%

CLOV Hedge Fund Activity: Q4 2024 in Review

178 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q4 2024, worth a combined $293M — up 27% from $231M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CLOV positions and 20 closed out — a net gain of 19 holders — while 62 added to existing stakes and 33 trimmed.

The largest buyer was Marshall Wace, adding an estimated $8.44M. The largest seller was Renaissance Technologies, cutting an estimated $5.05M.

  • 178 institutional investors held Clover Health Investments (CLOV) as of Q4 2024, up from 159 in Q3 2024.
  • Funds reported $293M of Clover Health Investments stock for Q4 2024, up 27% quarter-over-quarter.
  • 39 funds opened new Clover Health Investments positions in Q4 2024 and 20 closed out, a net change of +19 holders.
  • The largest Clover Health Investments buyer in Q4 2024 was Marshall Wace, an estimated $8.44M added.
  • The largest Clover Health Investments seller in Q4 2024 was Renaissance Technologies, an estimated $5.05M sold.

Based on aggregated 13F filings for Q4 2024.